logo
搜索
菜单

Pharmacolo的搜索结果

当前1/5页
排序: 最近更新
13.1: Drug Dosing: Infants and Children 01:29 min
13.1: Drug Dosing: Infants and Children
12.18: Pharmacokinetics: Drug–Food and Drug–Viral Interactions 01:26 min
12.18: Pharmacokinetics: Drug–Food and Drug–Viral Interactions
12.17: Pharmacokinetics: Drug–Drug Interactions 01:25 min
12.17: Pharmacokinetics: Drug–Drug Interactions
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
9.12: Equivalence: In Vitro and In Vivo Bioequivalence 01:17 min
9.12: Equivalence: In Vitro and In Vivo Bioequivalence
9.8: Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems 01:22 min
9.8: Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
9.7: Measurement of Bioavailability: Pharmacodynamic Methods 01:20 min
9.7: Measurement of Bioavailability: Pharmacodynamic Methods
The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity 10.3791/3674-v 07:00 min
The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation 10.3791/3671-v
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Paired Nanoinjection and Electrophysiology Assay to Screen for Bioactivity of Compounds using the Drosophila melanogaster Giant Fiber System 10.3791/3597-v 09:39 min
Paired Nanoinjection and Electrophysiology Assay to Screen for Bioactivity of Compounds using the Drosophila melanogaster Giant Fiber System
Transretinal ERG Recordings from Mouse Retina: Rod and Cone Photoresponses 10.3791/3424-v 08:38 min
Transretinal ERG Recordings from Mouse Retina: Rod and Cone Photoresponses
6.19: Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions 01:09 min
6.19: Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
6.17: Renal Drug Clearance: Comparison Between Renal Excretion Methods 01:08 min
6.17: Renal Drug Clearance: Comparison Between Renal Excretion Methods
5.12: Phase II Reactions: Methylation Reactions 01:17 min
5.12: Phase II Reactions: Methylation Reactions
5.9: Phase II Reactions: Sulfation and Conjugation with α-Amino Acids 01:19 min
5.9: Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
5.7: Phase II Conjugation Reactions: Overview 01:14 min
5.7: Phase II Conjugation Reactions: Overview
4.11: Factors Affecting Protein-Drug Binding: Drug-Related Factors 01:18 min
4.11: Factors Affecting Protein-Drug Binding: Drug-Related Factors
4.9: Tissue-Drug Binding: Localization of Drugs and its Significance 01:24 min
4.9: Tissue-Drug Binding: Localization of Drugs and its Significance
4.4: Factors Affecting Drug Distribution: Organ Perfusion Rate 01:15 min
4.4: Factors Affecting Drug Distribution: Organ Perfusion Rate
返回顶部